Powder: -20°C for 3 years
In solvent: -80°C for 2 years
hMAO-B-IN-5 is a potent reversible and selective human Monoamine Oxidase hMAO-B inhibitor (IC50:0.12μM). hMAO-B-IN-5 can cross the blood-brain barrier and can be used in the study of Parkinson's disease. It is a promising compound in the treatment and diagnosis of central nervous system diseases.
Description | hMAO-B-IN-5 is a potent reversible and selective human monoamine oxidase hMAO-B inhibitor (IC50:0.12μM). hMAO-B-IN-5 can cross the blood-brain barrier and can be used in the study of Parkinson's disease. It is a promising compound in the treatment and diagnosis of central nervous system diseases. |
Targets&IC50 | hMAO-B:0.12μM |
In vivo | hMAO-B-IN-5 can pass through the blood-brain barrier and can be used in the research of neurodegenerative diseases.[1] |
Molecular Weight | 358.43 |
Formula | C24H22O3 |
CAS No. | 358343-63-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 27.5 mg/mL (76.72 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
hMAO-B-IN-5 358343-63-2 Metabolism Neuroscience Monoamine Oxidase MAO Inhibitor inhibitor inhibit